ATE237611T1 - Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer - Google Patents

Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer

Info

Publication number
ATE237611T1
ATE237611T1 AT98930064T AT98930064T ATE237611T1 AT E237611 T1 ATE237611 T1 AT E237611T1 AT 98930064 T AT98930064 T AT 98930064T AT 98930064 T AT98930064 T AT 98930064T AT E237611 T1 ATE237611 T1 AT E237611T1
Authority
AT
Austria
Prior art keywords
cycloheptapyridines
benzo
protein transferase
transferase inhibitors
cyclic urea
Prior art date
Application number
AT98930064T
Other languages
English (en)
Inventor
F George Njoroge
Bancha Vibulbhan
Patrick A Pinto
Viyyoor M Girijavallabhan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE237611T1 publication Critical patent/ATE237611T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
AT98930064T 1997-06-17 1998-06-15 Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer ATE237611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/877,399 US5852034A (en) 1997-06-17 1997-06-17 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
PCT/US1998/011502 WO1998057963A1 (en) 1997-06-17 1998-06-15 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors

Publications (1)

Publication Number Publication Date
ATE237611T1 true ATE237611T1 (de) 2003-05-15

Family

ID=25369892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930064T ATE237611T1 (de) 1997-06-17 1998-06-15 Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer

Country Status (15)

Country Link
US (2) US5852034A (de)
EP (1) EP0991644B1 (de)
JP (1) JP3515787B2 (de)
KR (1) KR20010013892A (de)
CN (1) CN1267297A (de)
AT (1) ATE237611T1 (de)
AU (1) AU744182B2 (de)
CA (1) CA2293712C (de)
DE (1) DE69813554T2 (de)
ES (1) ES2195352T3 (de)
HK (1) HK1024909A1 (de)
HU (1) HUP0004521A3 (de)
IL (1) IL133414A0 (de)
NZ (1) NZ501570A (de)
WO (1) WO1998057963A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6130229A (en) * 1996-10-09 2000-10-10 Schering Corporation Tricyclic compounds having activity as RAS-FPT inhibitors
US6211193B1 (en) * 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6271378B1 (en) 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ATE323474T1 (de) * 2000-02-04 2006-05-15 Janssen Pharmaceutica Nv Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
AU3514302A (en) 2000-11-29 2002-06-11 Schering Corp 0ovel farnesyl protein transferase inhibitors
US20070148660A1 (en) * 2005-06-16 2007-06-28 The Regents Of The University Of California Treatment of maladaptive substance use with H-ras antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
KR20000036111A (ko) * 1996-09-13 2000-06-26 둘락 노먼 씨. 파네실 단백질 트랜스페라제 억제제인 트리사이클릭 항종양성화합물

Also Published As

Publication number Publication date
AU7953898A (en) 1999-01-04
CA2293712C (en) 2004-01-06
EP0991644B1 (de) 2003-04-16
JP3515787B2 (ja) 2004-04-05
HUP0004521A3 (en) 2002-01-28
JP2000513033A (ja) 2000-10-03
NZ501570A (en) 2001-06-29
EP0991644A1 (de) 2000-04-12
CA2293712A1 (en) 1998-12-23
US6039683A (en) 2000-03-21
DE69813554T2 (de) 2004-02-26
AU744182B2 (en) 2002-02-14
HK1024909A1 (en) 2000-10-27
ES2195352T3 (es) 2003-12-01
CN1267297A (zh) 2000-09-20
IL133414A0 (en) 2001-04-30
WO1998057963A1 (en) 1998-12-23
HUP0004521A2 (hu) 2001-10-28
KR20010013892A (ko) 2001-02-26
DE69813554D1 (de) 2003-05-22
US5852034A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
AU554362B2 (en) Carboxyalkyl dipeptides
NZ332658A (en) Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ATE237611T1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
ATE209201T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
NO991235D0 (no) Forbindelser anvendelige for inhibering av farnesylproteintransferase
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DE69201184D1 (de) 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
FI953618A (fi) Kondensoituneita heterosyklisiä glutamiinijohdannaisia antiproliferatiivisina aineina
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
AU1847401A (en) Diketopiperazine derivatives to inhibit thrombin
DE69724130D1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl protein transferase inhibitoren
NO991231D0 (no) Forbindelser for inhibering av farnesylproteintransferase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties